Literature DB >> 10461536

Pulmonary veno-occlusive disease.

S Veeraraghavan1, M N Koss, O P Sharma.   

Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension that mainly affects children and young adults. Its cause is unknown, although viral infections and drugs have been implicated. Patients with PVOD present with symptoms of right-sided heart failure. Radiologic examination shows prominent pulmonary arteries with Kerley B lines, pleural effusion, and mediastinal adenopathy. The definite diagnosis is made by histologic examination. Eccentric intimal fibrosis and recanalized thrombi in pulmonary veins and venules, arterialized veins, alveolar edema, and medial hypertrophy of arteries are seen on lung biopsy. No effective treatment is available; lung transplantation has been tried. The prognosis associated with PVOD is poor.

Entities:  

Mesh:

Year:  1999        PMID: 10461536     DOI: 10.1097/00063198-199909000-00008

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  4 in total

1.  Pulmonary veno-occlusive disease: an uncommon cause of pulmonary hypertension.

Authors:  Kyle Masters; Steven Bennett
Journal:  BMJ Case Rep       Date:  2013-02-01

2.  Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.

Authors:  Keith M Wille; Nirmal S Sharma; Tejaswini Kulkarni; Matthew R Lammi; Joseph B Barney; S Christopher Bellot; Ryan S Cantor; David C Naftel; Enrique Diaz-Guzman; David C McGiffin
Journal:  Ann Am Thorac Soc       Date:  2014-11

3.  Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension.

Authors:  Moloud Rabieyousefi; Pejman Soroosh; Kimio Satoh; Fumiko Date; Naoto Ishii; Masahiro Yamashita; Masahiko Oka; Ivan F McMurtry; Hiroaki Shimokawa; Masato Nose; Kazuo Sugamura; Masao Ono
Journal:  BMC Immunol       Date:  2011-12-15       Impact factor: 3.615

4.  MicroRNA‑15a‑5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP‑2 signaling pathway.

Authors:  Wenmei Zhang; Yanna Li; Xin Xi; Guangfa Zhu; Shenghao Wang; Yan Liu; Man Song
Journal:  Int J Mol Med       Date:  2019-12-18       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.